End-of-Life Decisions and Palliative Care in Advanced Heart Failure

Abstract Advanced heart failure (HF) therapies are focused on extending life and improving function. In contrast, palliative care (PC) is a holistic approach that focuses on symptom alleviation and patients’ physical, psychosocial, and spiritual needs. Heart failure clinicians can integrate PC strat...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Canadian journal of cardiology 2016-09, Vol.32 (9), p.1148-1156
Hauptverfasser: Meyers, Deborah E., MD, FRACP, FACC, Goodlin, Sarah J., MD, FACC, FAAHPM
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Abstract Advanced heart failure (HF) therapies are focused on extending life and improving function. In contrast, palliative care (PC) is a holistic approach that focuses on symptom alleviation and patients’ physical, psychosocial, and spiritual needs. Heart failure clinicians can integrate PC strategies by incorporating several important components of planning and decision-making for HF patients. Future care planning (FCP) for HF patients should incorporate the basic tenets of shared decision-making (SDM). These include understanding the patient’s perspective and care preferences, articulating what is medically feasible, and integrating these considerations into the overall care plan. Use of defined triggers for FCP can stimulate important patient-caregiver conversations. Guidelines advocate an annual review of HF status and future care preferences. Advance directives are important for any individual with a chronic, life-limiting illness and should be integrated into FCP. Nevertheless, use of advance directives by HF patients is extremely low. Consideration of illness trajectories and risk-scoring tools may facilitate prognostication and delivery of appropriate HF care. Decisions about heart transplantation or left ventricular assist device implantation should include planning for potential complications associated with these therapies. Such decisions also should include a discussion of palliative management, both as an alternative to intervention and as an option for managing symptoms or adverse events after intervention. Palliative care, including FCP and SDM, should be integrated into the course of all patients with advanced HF. Clinicians who provide HF care should acquire the skills necessary for conducting FCP and SDM discussions.
ISSN:0828-282X
1916-7075
DOI:10.1016/j.cjca.2016.04.015